Your browser doesn't support javascript.
loading
FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion.
Oldham, Robert J; Mockridge, C Ian; James, Sonya; Duriez, Patrick J; Chan, H T Claude; Cox, Kerry L; Pitic, Vicentiu A; Glennie, Martin J; Cragg, Mark S.
Afiliación
  • Oldham RJ; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
  • Mockridge CI; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
  • James S; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
  • Duriez PJ; Southampton Experimental Cancer Medicine/CRUK Centre, Protein Core Facility, University of Southampton Faculty of Medicine, Southampton, UK.
  • Chan HTC; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
  • Cox KL; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
  • Pitic VA; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
  • Glennie MJ; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
  • Cragg MS; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK msc@soton.ac.uk.
J Immunother Cancer ; 8(1)2020 06.
Article en En | MEDLINE | ID: mdl-32554613

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulina G / Leucemia Linfocítica Crónica de Células B / Receptores de IgG / Rituximab / Antineoplásicos Inmunológicos / Neoplasias Experimentales Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulina G / Leucemia Linfocítica Crónica de Células B / Receptores de IgG / Rituximab / Antineoplásicos Inmunológicos / Neoplasias Experimentales Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido